
Phase III aducanumab trials for Alzheimer’s disease stopped early
Pharmaceutical companies Biogen and Eisai today (Thursday 21 March) announced they are to discontinue two phase III trials of the Alzheimer’s drug aducanumab. The ENGAGE […]
Home »
Pharmaceutical companies Biogen and Eisai today (Thursday 21 March) announced they are to discontinue two phase III trials of the Alzheimer’s drug aducanumab. The ENGAGE […]
Phase III aducanumab trials for Alzheimer’s disease stopped early
Copyright © 2023